CHF148.80
0.68% today
SIX Swiss Exchange, Oct 31, 05:31 pm CET
ISIN
CH0468525222
Symbol
MOVE

Medacta Stock price

CHF148.80
+3.00 2.06% 1M
+15.60 11.71% 6M
+42.20 39.59% YTD
+34.00 29.62% 1Y
+58.70 65.15% 3Y
+71.10 91.51% 5Y
+52.70 54.84% 10Y
+52.70 54.84% 20Y
SIX Swiss Exchange, Closing price Fri, Oct 31 2025
+1.00 0.68%
ISIN
CH0468525222
Symbol
MOVE

Key metrics

Basic
Market capitalization
CHF2.9b
Enterprise Value
CHF3.1b
Net debt
CHF198.6m
Cash
CHF37.7m
Shares outstanding
19.9m
Valuation (TTM | estimate)
P/E
33.5 | 36.3
P/S
4.9 | 4.6
EV/Sales
5.2 | 4.9
EV/FCF
130.0
P/B
7.4
Dividends
DPS
CHF0.69
Yield 1Y | 5Y
0.5% | 0.4%
Growth 1Y | 5Y
25.5% | -
Payout 1Y | 3Y
20.4% | 23.0%
Increased
4 Years
Financials (TTM | estimate)
Revenue
CHF599.1m | CHF642.5m
EBITDA
CHF165.2m | CHF175.3m
EBIT
CHF100.0m | CHF103.9m
Net Income
CHF88.0m | CHF81.2m
Free Cash Flow
CHF24.0m
Growth (TTM | estimate)
Revenue
18.7% | 17.3%
EBITDA
27.0% | 65.8%
EBIT
38.4% | 18.8%
Net Income
68.9% | 20.2%
Free Cash Flow
267.1%
Margin (TTM | estimate)
Gross
67.6%
EBITDA
27.6% | 27.3%
EBIT
16.7%
Net
14.7% | 12.6%
Free Cash Flow
4.0%
Financial Health
Equity Ratio
47.9%
Return on Equity
19.2%
ROCE
16.0%
ROIC
12.2%
Debt/Equity
0.6
More
EPS
CHF4.4
FCF per Share
CHF1.2
Short interest
-
Employees
2k
Rev per Employee
CHF290.0k
Show more

Is Medacta a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,030 stocks worldwide.

Medacta Stock Analysis

Unlock Scores for Free

Analyst Opinions

12 Analysts have issued a Medacta forecast:

10x Buy
83%
2x Hold
17%

Analyst Opinions

12 Analysts have issued a Medacta forecast:

Buy
83%
Hold
17%

Financial data from Medacta

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
599 599
19% 19%
100%
- Direct Costs 194 194
20% 20%
32%
405 405
18% 18%
68%
- Selling and Administrative Expenses 285 285
13% 13%
48%
- Research and Development Expense 20 20
6% 6%
3%
165 165
27% 27%
28%
- Depreciation and Amortization 65 65
13% 13%
11%
EBIT (Operating Income) EBIT 100 100
38% 38%
17%
Net Profit 88 88
69% 69%
15%

In millions CHF.

Don't miss a Thing! We will send you all news about Medacta directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Medacta Stock News

AD HOC NEWS
6 months ago
Medacta Group SA / CH0468525222

Company Profile

Medacta Group SA engages in the development, manufacture, and distribution of orthopedic and neurosurgical medical devices. The firm offers personalized kinematic models and three-dimensional planning tools for use in hip, knee, shoulder, and spine procedures. It operates through the following geographical segments: Europe, North America, Asia Pacific, and Rest of the World. The company was founded by Alberto Siccardi in 1999 and is headquartered in Castel San Pietro, Switzerland.

Head office Switzerland
CEO Francesco Siccardi
Employees 1,907
Founded 1999
Website www.medacta.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today